General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0BRHCV
ADC Name
KM254-ADC
Synonyms
KM254 ADC; KM254ADC
   Click to Show/Hide
Organization
Xuanzhu Biopharmaceutical Co., Ltd.
Drug Status
Investigative
Indication
In total 4 Indication(s)
Breast cancer
Clinical candidate
.
Colorectal cancer
Clinical candidate
.
Gastric cancer
Clinical candidate
.
Lung cancer
Clinical candidate
.
Antibody Name
Undisclosed
Antigen Name
Receptor tyrosine-protein kinase erbB-2 (HER2)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed